BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36228756)

  • 1. Elucidating a Potential Mechanism of Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl) amino] Caprylate in Rats: Evidence of Lymphatic Absorption of Cyanocobalamin using the Mesenteric Lymph Duct Cannulated Rat.
    Chiang PC; Liu J; Nagapudi K; Wu R; Dolton M; Chen J; Plise E; Liu L; Durk MR
    J Pharm Sci; 2022 Dec; 111(12):3417-3423. PubMed ID: 36228756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the Pharmacokinetics and Systemic Effects of a Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl)amino] Caprylate in Rats.
    Chiang PC; Deshmukh G; Liu J; Nagapudi K; Chen JZ; Valle N; Li R; Plise EG; Durk MR
    J Pharm Sci; 2020 Aug; 109(8):2629-2636. PubMed ID: 32360544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjects.
    Castelli MC; Wong DF; Friedman K; Riley MG
    Clin Ther; 2011 Jul; 33(7):934-45. PubMed ID: 21722960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Sodium
    Li Y; Yang D; Zhu C
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and In Vitro and In Vivo Evaluation of Microspheres Containing Sodium
    Li Y; Zhu C
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32340157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and barrier changes in gastrointestinal mucus induced by the permeation enhancer sodium 8-[(2-hydroxybenzoyl)amino]octanoate (SNAC).
    Mortensen JS; Bohr SS; Harloff-Helleberg S; Hatzakis NS; Saaby L; Nielsen HM
    J Control Release; 2022 Dec; 352():163-178. PubMed ID: 36314534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of QTc Prolongation with Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (SNAC), an Absorption Enhancer Co-Formulated with the GLP-1 Analogue Semaglutide for Oral Administration.
    Granhall C; Bækdal TA; Breitschaft A; Søndergaard FL; Anderson TW; Thomsen M
    Diabetes Ther; 2021 Sep; 12(9):2599-2610. PubMed ID: 34319564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal absorptivity-increasing effects of sodium N-[8-(2-hydroxybenzoyl)amino]-caprylate on food-derived bioactive peptide.
    Xu Y; Amakye WK; Xiao G; Liu X; Ren J; Wang M
    Food Chem; 2023 Feb; 401():134059. PubMed ID: 36095999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method.
    Hess S; Rotshild V; Hoffman A
    Eur J Pharm Sci; 2005 Jun; 25(2-3):307-12. PubMed ID: 15911227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers.
    Brayden D; Creed E; O'Connell A; Leipold H; Agarwal R; Leone-Bay A
    Pharm Res; 1997 Dec; 14(12):1772-9. PubMed ID: 9453067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on gastrointestinal absorption enhancement effect and mechanism of sodium N-[8-(2-hydroxybenzyl)amino] caprylate to insulin solution].
    Qi R; Ping QN; Zhao W
    Yao Xue Xue Bao; 2003 Dec; 38(12):953-6. PubMed ID: 15040094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
    Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
    Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathway of oral absorption of heparin with sodium N-[8-(2-hydroxybenzoyl)amino] caprylate.
    Malkov D; Wang HZ; Dinh S; Gomez-Orellana I
    Pharm Res; 2002 Aug; 19(8):1180-4. PubMed ID: 12240944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral absorption enhancement of cromolyn sodium through noncovalent complexation.
    Ding X; Rath P; Angelo R; Stringfellow T; Flanders E; Dinh S; Gomez-Orellana I; Robinson JR
    Pharm Res; 2004 Dec; 21(12):2196-206. PubMed ID: 15648250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative.
    Alani AW; Robinson JR
    Pharm Res; 2008 Jan; 25(1):48-54. PubMed ID: 17846867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal absorption enhancement of insulin by administration of enteric microspheres and SNAC to rats.
    Qi R; Ping QN
    J Microencapsul; 2004 Feb; 21(1):37-45. PubMed ID: 14718184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Understanding of Sodium N-(8-[2-Hydroxylbenzoyl] Amino) Caprylate (SNAC) as an Absorption Enhancer: The Oral Semaglutide Experience.
    Solis-Herrera C; Kane MP; Triplitt C
    Clin Diabetes; 2024; 42(1):74-86. PubMed ID: 38230324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNAC for Enhanced Oral Bioavailability: An Updated Review.
    Kommineni N; Sainaga Jyothi VGS; Butreddy A; Raju S; Shapira T; Khan W; Angsantikul P; Domb AJ
    Pharm Res; 2023 Mar; 40(3):633-650. PubMed ID: 36539668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral delivery of insulin with the eligen technology: mechanistic studies.
    Malkov D; Angelo R; Wang HZ; Flanders E; Tang H; Gomez-Orellana I
    Curr Drug Deliv; 2005 Apr; 2(2):191-7. PubMed ID: 16305420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally administered heparin for preventing deep venous thrombosis.
    Gonze MD; Manord JD; Leone-Bay A; Baughman RA; Garrard CL; Sternbergh WC; Money SR
    Am J Surg; 1998 Aug; 176(2):176-8. PubMed ID: 9737627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.